Apexigen, Inc.
APGNDelisted Aug 23, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001814140
Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Apexigen, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −2 vs. Q3 2022
- Shares held
- 3.16M
- +21.7K (+0.7%) vs. Q3 2022
- Total value
- $2.16M
- −$6.32M (−74.5%) vs. Q3 2022
- New holders
- 3
- 4 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 17 | $1.37M |
| Q1 2023 | 20 | $1.64M |
| Q4 2022 | 15 | $2.16M |
| Q3 2022 | 17 | $8.48M |
| Q2 2022 | 1 | $912.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Apexigen, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 127 | $87 | 0.00% | +3+2.4% | Added |
| UBS Group AG | 10,033 | $6.82K | 0.00% | +2,071+26.0% | Added |
| Tower Research Capital LLC (TRC) | 10,308 | $7.00K | 0.00% | +10,191+8,710.3% | Added |
| Susquehanna International Group, LLP | 11,851 | $8.18K | 0.00% | +11,851 | New |
| Destination Wealth Management | 13,216 | $9.01K | 0.00% | +13,216 | New |
| Jane Street Group, LLC | 17,799 | $12.1K | 0.00% | −16,622−48.3% | Reduced |
| Citadel Advisors LLC | 25,624 | $17.7K | 0.00% | −26,766−51.1% | Reduced |
| Northern Trust Corp | 31,041 | $21.2K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 43,626 | $30.0K | 0.00% | +43,626 | New |
| State Street Corp | 54,300 | $37.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 178,760 | $123.0K | 0.00% | −380−0.2% | Reduced |
| BlackRock Inc. | 213,833 | $145.8K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 256,935 | $175.2K | 0.00% | +380+0.1% | Added |
| Fan Yu | 401,757 | $274.0K | 3.67% | 00.0% | Unchanged |
| Decheng Capital Management III (Cayman), LLC | 1,894,551 | $1.29M | 0.48% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −13,934−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −196−100.0% | Sold out |